The U.S. Food and Drug Administration plans to approve the use of unfinished COVID-19 vaccine, The vice chairman of the U.S. Federal Reserve said that the unemployment rate alone is not enough to form conditions for raising interest rates.

In Daily Market Review, English
September 01, 2020

The U.S. Food and Drug Administration plans to approve the use of unfinished COVID-19 vaccine
In an interview with the Financial Times, the US Food and Drug Administration Director Hahn said that the bureau is planning to approve the use of the unfinished third-stage COVID-19 vaccine, and the authorities are ready to approve the unfinished third-stage clinical use through emergency authorization. New coronary pneumonia vaccine tested. Currently, two vaccines in the United States have entered the third phase of testing, and there are still two more vaccines in mid-September. In order to confirm the safety of vaccines, pharmaceutical companies often recruit at least 30,000 people for testing. The market believes that skipping the third phase of clinical testing is not safe. But Hahn emphasized that the vaccine will only be authorized for use by specific groups, rather than fully approved for use. In other words, the vaccine is still far from reaching the stage of universal use.

The vice chairman of the U.S. Federal Reserve said that the unemployment rate alone is not enough to form conditions for raising interest rates.
Clarinda, vice chairman of the U.S. Federal Reserve, said when attending the economic forum that the unemployment rate alone has fallen, but inflation has not been maintained or is expected to rise above the target level of 2%. Under the new monetary policy framework of the Fed, it is still not enough Interest rate hike conditions. In addition, Clarinda does not believe that negative interest rates are an attractive policy. His comments suggest that the bureau does not tend to implement a negative interest policy, and under the new monetary policy framework, the threshold for the bureau to raise interest rates in the future will be quite high.

—————————————————————

Z. com Bullion is an affiliate of GMO Financial Holdings, Inc., a Japanese listed group. The risk of loss in leveraged foreign exchange trading & margin trading can be substantial. Visit the company website to read full risk warning. https://bullion.z.com/en/about/legal/risk/

場外式黃金/白銀交易的風險:
Service relating to Over-the-counter (OTC) Gold Bullion/Silver trading is provided by MOL. OTC Gold/Silver Bullion trading carries a high degree of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. OTC Gold/Silver Bullion is not regulated by the Securities and Futures Commission (""SFC"") and therefore trading OTC Gold/Silver Bullion will not be subject to rules or regulations promulgated by the SFC. Before deciding to trade OTC Gold/Silver Bullion you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain losses in excess of your deposited fund or even more in extreme circumstances and therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading OTC Gold/Silver Bullion, and seek advice from an independent financial advisor if you require.